TWiV 764: COVID-19 clinical update #65 with Dr. Daniel Griffin

In COVID-19 clinical update #65, Daniel Griffin summarizes effects of non-pharmaceutical interventions, updated summer camp guidance from CDC, serology testing not recommended by FDA, antigen tests during a music event, inhibition of vaccine immunogenicity by methotrexate, phase 3 trial results for colchicine, and small airway disease as a post-acute sequelae. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Effects of vaccines and NPIs (JAMA) Guidance on summer camps (CDC) Antibody testing not recommended (FDA) Antigen testing at a music event (Lancet) Methotrexate and vaccine immunogenicity (Ann Rheum Dis) Colchicine phase 3 results (Lancet Resp Med) Small airway disease a post-acute sequelae (medRxiv) Letters read on TWiV 764 Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]